KITE
Kite Pharma Inc
Clinical-stage biopharmaceutical company developing cancer immunotherapies
CUSIP: 49803L109HealthcareUS1 holder
Total Value
$126.28M
Total Shares
2.53M
Net Share Change
+265.7K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$126.28M2.53M shares
ADD+265.7K(+11.8%)